Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

14.92
+0.35002.40%
Post-market: 14.920.00000.00%16:05 EDT
Volume:1.10M
Turnover:16.26M
Market Cap:1.32B
PE:-3.66
High:15.00
Open:14.56
Low:14.56
Close:14.57
Loading ...
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 22, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2023

Major Issues Report

Form 8-K - Current report
Apr 12, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 01, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 01, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals